Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells
References (31)
- et al.
Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
Hum Pathol
(1993) - et al.
Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
Anal Biochem
(1987) - et al.
Human monocyte chemoattractant protein-1 (MCP-1): Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE
FEBS Lett
(1989) - et al.
Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells
Atherosclerosis
(1993) - et al.
Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: Effect of nutritionally induced atherosclerosis
Lipid Res
(1969) - et al.
Regulation of protein kinase C by lysophospholipids
J Biol Chem
(1988) - et al.
Platelet-activating factor
J Biol Chem
(1990) - et al.
Human endothelial cells are targets for platelet-activating factor (PAF)
J Biol Chem
(1994) - et al.
Structure of human monocyte chemotactic protein gene and its regulation by TPA
Biochem Biophys Res Commun
(1990) The pathogenesis of atherosclerosis: A perspective for the 1990s
Nature
(1993)
The role of the monocyte in atherogenesis. I. Transition of blood-borne monocyte into foam cells in fatty lesions
Am J Pathol
(1981)
Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE
Am J Pathol
(1990)
Monocyte chemoattractant protein-1 in human atheromatous plaques
J Clin Invest
(1991)
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates
Modifications of low-density lipoprotein that increase its atherogenicity
N Engl J Med
(1989)
Cited by (0)
Copyright © 1996 Published by Elsevier Inc.